- Nový kinázový inhibitor: entrectinib2020 | Third Faculty of Medicine
- Allogeneic hematopoietic cell transplantation and cellular therapy in CLL2019 | First Faculty of Medicine
- Efficacy of Janus kinase inhibitors on skin syndrome in patients with psoritic arthritis2022 | First Faculty of Medicine
- Abrocitinib2022 | Faculty of Medicine in Pilsen
- Janus kinase inhibitors in clinical practice: data from the ATTRA registry2020 | First Faculty of Medicine
- Current trends in immunosuppressive treatment2019 | Second Faculty of Medicine
- Testing algorithm for identification of patients with NTRK gene fusions in malignancies in the era of precision medicine and targete therapy with larotrectinib2019 | Faculty of Medicine in Pilsen
- Renální toxicita cílené léčby v onkologii2023 | First Faculty of Medicine
- Atypická velmi pomalá regrese metastáz melanomu při léčbě vemurafenibem2016 | First Faculty of Medicine
- Recent advances in tartgeted therapy of renal cell carcinoma2016 | First Faculty of Medicine
- Treatment of relapsed chronic lymphocytic leukemia2019 | First Faculty of Medicine